Clinicians now have the first oral alternative to injectable therapy for gonorrhea, a shift Angela Hasler, APRN, CPNP-PC says could ease treatment barriers and improve public health outcomes.
Angela Hasler, APRN, CPNP-PC
Advertisement
Angela Hasler, APRN, CPNP-PC, pediatric nurse practitioner, Adolescent and Young Adult Medicine, Children’s National Hospital, Washington D.C.; National Association of Pediatric Nurse Practitioners member
Articles by Angela Hasler, APRN, CPNP-PC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
2
FDA approves powder formulation of trofinetide for Rett syndrome
3
Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV
4
FDA approves berotralstat for patients aged 2 to <12 years with hereditary angioedema
5
